Akebia Therapeutics (AKBA) Other Non-Current Assets (2013 - 2026)
Akebia Therapeutics' Other Non-Current Assets was $53.75 million in Q2 2026, up 21.6% from $44.19 million a year earlier but down 5.0% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Other Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Other Non-Current Assets at Akebia Therapeutics came in at $59.68 million, up 59.7% from FY2024.
- Other Non-Current Assets has now increased for three consecutive years, with a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
- In earlier years, Other Non-Current Assets was $37.38 million in FY2024 (+200.9%), $12.42 million in FY2023 (+131.3%), $5.37 million in FY2022 (-89.3%) and $50.42 million in FY2021 (+32.8%).
- Quarterly Other Non-Current Assets has moved between $3.35 million (Q2 2023) and $69.6 million (Q3 2021) over five years.
- Compared with a year earlier, Other Non-Current Assets has increased for 11 straight quarters, with growth averaging 169.4% over the last eight quarters.
- The best year-over-year quarter for Other Non-Current Assets over five years was Q3 2024 (growth of 602.6%); the worst was Q2 2023 (a decline of 90.4%).
- Per Business Quant data, AKBA's Other Non-Current Assets in the three quarters before Q2 2026 was $56.57 million (Q1 2026), $59.68 million (Q4 2025) and $40.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Akebia Therapeutics | 250.00 Mn | -419.48 Mn | 38.70 Mn | 53.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.75 Mn |
| Mar 31, 2026 | 56.57 Mn |
| Dec 31, 2025 | 59.68 Mn |
| Sep 30, 2025 | 40.46 Mn |
| Jun 30, 2025 | 44.19 Mn |
| Mar 31, 2025 | 38.34 Mn |
| Dec 31, 2024 | 37.38 Mn |
| Sep 30, 2024 | 27.13 Mn |
| Jun 30, 2024 | 17.78 Mn |
| Mar 31, 2024 | 11.79 Mn |
| Dec 31, 2023 | 12.42 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | 5.37 Mn |
| Sep 30, 2022 | 25.94 Mn |
| Jun 30, 2022 | 34.95 Mn |
| Mar 31, 2022 | 39.42 Mn |
| Dec 31, 2021 | 50.42 Mn |
| Sep 30, 2021 | 69.60 Mn |
API Access
Akebia Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();